Blood:肽聚糖可通过激活两条凝血通路诱导弥散性血管内凝血

2018-06-20 MedSci MedSci原创

中心点:输注肽聚糖可模拟晚期炭疽杆菌感染的全身炎症和凝血障碍。在非人的灵长类动物中,肽聚糖可直接激活外源性凝血,放大接触信号。摘要:炭疽感染表现为进行性凝血障碍,可导致在暴发性疾病中所见的脓毒症。在晚期疾病的灵长类动物模型中可再现凝血失衡,但在败血症模型中不常见,提示其他细菌病原体感染可影响分子图谱(PAMPs)。肽聚糖(PGN)是一种细菌PAMP,在先天性免疫和止血的交联中充作细胞组分。Narc

中心点:

输注肽聚糖可模拟晚期炭疽杆菌感染的全身炎症和凝血障碍。

在非人的灵长类动物中,肽聚糖可直接激活外源性凝血,放大接触信号。

摘要:

炭疽感染表现为进行性凝血障碍,可导致在暴发性疾病中所见的脓毒症。在晚期疾病的灵长类动物模型中可再现凝血失衡,但在败血症模型中不常见,提示其他细菌病原体感染可影响分子图谱(PAMPs)。肽聚糖(PGN)是一种细菌PAMP,在先天性免疫和止血的交联中充作细胞组分。Narcis I. Popescu等人推测PGN对炭疽诱导的凝血障碍至关重要,并在灵长类动物中研究注射无菌PGN是否可促进凝血。

用PGN刺激,类似营养性细菌,可诱导败血症样病理生理改变,表现为全身炎症、弥散性血管内凝血、器官功能障碍和存活受损。重要的是,凝血受损出现较早,伴随炎症反应,提示凝血通路直接参与。给狒狒注射PGN可促进接触因子早期激活,并通过蛋白酶-丝氨酸蛋白酶抑制剂复合物升高得到证实。

虽然与接触因子结合,但PGN并不直接激活FXII或激肽释放酶原。PGN通过增强活化FXII(FXIIa)的酶功能、抑制抗凝血酶介导的抑制作用来支持接触凝血。

与此同时,PGN在体内外均可诱导新发单核细胞TF表达,从而促进后期外源性凝血反应。在PGN刺激期间,血小板活化可进一步放大促凝血状态,导致弥散性血管内凝血和周围组织缺血性损伤。

本研究结果提示PGN可能是炭疽杆菌败血症的病理进展的主要原因,是导致晚期炭疽热病原体诱导的凝血障碍的主要PAMP。

原始出处:

Narcis I. Popescu,et al.Peptidoglycan induces disseminated intravascular coagulation in baboons through activation of both coagulation pathways. Blood  2018  :blood-2017-10-813618;  doi: https://doi.org/10.1182/blood-2017-10-813618

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=325789, encodeId=f621325e8974, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Jun 21 08:00:47 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325712, encodeId=1947325e1293, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Jun 21 00:07:36 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325689, encodeId=4e42325689ea, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Jun 20 23:43:28 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325658, encodeId=1538325658f3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Jun 20 21:51:37 CST 2018, time=2018-06-20, status=1, ipAttribution=)]
    2018-06-21 kafei

    学习了谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=325789, encodeId=f621325e8974, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Jun 21 08:00:47 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325712, encodeId=1947325e1293, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Jun 21 00:07:36 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325689, encodeId=4e42325689ea, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Jun 20 23:43:28 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325658, encodeId=1538325658f3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Jun 20 21:51:37 CST 2018, time=2018-06-20, status=1, ipAttribution=)]
    2018-06-21 飛歌

    学习了很有用不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=325789, encodeId=f621325e8974, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Jun 21 08:00:47 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325712, encodeId=1947325e1293, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Jun 21 00:07:36 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325689, encodeId=4e42325689ea, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Jun 20 23:43:28 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325658, encodeId=1538325658f3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Jun 20 21:51:37 CST 2018, time=2018-06-20, status=1, ipAttribution=)]
    2018-06-20 changjiu

    学习一下谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=325789, encodeId=f621325e8974, content=学习了谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLbTp9nZtjwVrSZNxAXbAicnKQWnic2eBdJUQYhxO36XdkstSicr7FVF8p5ReH4omtmsbnLdvZLiaJJ1A/132, createdBy=8bff2327056, createdName=kafei, createdTime=Thu Jun 21 08:00:47 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325712, encodeId=1947325e1293, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Thu Jun 21 00:07:36 CST 2018, time=2018-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325689, encodeId=4e42325689ea, content=学习一下谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Wed Jun 20 23:43:28 CST 2018, time=2018-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325658, encodeId=1538325658f3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Wed Jun 20 21:51:37 CST 2018, time=2018-06-20, status=1, ipAttribution=)]
    2018-06-20 医者仁心5538

    学习了

    0

相关资讯

Nature:打破半个世纪的“衣原体异常”悖论

对于绝大多数细菌来说,肽聚糖是细胞壁的必要结构组分,对于细胞形态的维持和细胞分裂非常重要。科学家们早就知道,衣原体拥有与肽聚糖合成有关的基因,且衣原体感染可以用抗生素治疗(可终止肽聚糖的合成)。但半个世纪以来,科学家始终未能在衣原体中检测到肽聚糖。这就是著名的“衣原体异常”悖论。 现在,来自印第安纳大学(Indiana University)的科学家们开发了一种新的代谢型细胞